Background: Central hyperthermia is an unresolved riddle; this study tries to define its characteristics. Methods: Seventy-four previously healthy patients who developed hyperthermia (≥39°C) within 24 h after stroke onset were enrolled. The lesion sites, nature of stroke, and clinical features were studied. Results: Brainstem hemorrhage was the most common cause of hyperthermia (64%), followed by putamino-thalamus hemorrhage (24%), cerebellum hemorrhage (4%), large cortical infarct (4%), basilar artery occlusion (3%), and intraventricular hemorrhage (1%). Whatever the site of the lesion, all patients had brainstem involvement either by direct destruction or indirect compression. Three fourths of the patients reached 39°C within 12 h of stroke, and 82% arrived at the maximum within 24 h. A peculiar finding of central hyperthermia was the marked fluctuation in body temperature within a short period, which was more severe initially then decreased gradually. Leukocytosis was seen in 60%, but shift to the left was rare (1%). The prognosis was grave, nearly 70% of the patients expired within 1 month, especially those with a temperature of >41°C or those who reached 39°C within 6 h after onset of stroke, or those who had severe fluctuations in temperature. Conclusions: Central hyperthermia is characterized by rapid onset of high fever, marked temperature fluctuation and high mortality. It is likely associated with brainstem (mainly pons) damage by direct destruction or indirect compression.

1.
Erickson TC: Neurogenic hyperthermia (a clinical syndrome and its treatment). Brain 1939;62:172–190.
2.
Kitanaka C, Inoh Y, Toyoda T, Sasaki T, Eguchi T: Malignant brain stem hyperthermia caused by brain stem hemorrhage. Stroke 1994;25:518–520.
3.
Cunha BA, Tu RP: Fever in the neurosurgical patient. Heart Lung 1988;17:608–611.
4.
Chin RL, Gelb A: High temperature with cerebral hemorrhage. Ann Emerg Med 1999;34:411. Letter.
5.
Schwarz S, Hafner K, Aschoff A, Schwab S: Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000;54:354–361.
6.
Morales-Ortiz A, Jimenez-Pascual M, Perez-Vicente JA, Monge-Arguiles A, Bautista-Prados J: Fever of central origin during stroke (in Spanish). Rev Neurol 2001;32:1111–1114.
7.
Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K: Aetiology of fever in patients with acute stroke. J Intern Med 1999;246:203–209.
8.
Dinarello CA, Gelfand JA: Fever and hyperthermia; in Kasper DL, Fauci AS, Longo DL, et al. (eds): Harrison’s Principles of Internal Medicine, ed 16. New York, McGraw-Hill, 2005, pp 104–108.
9.
Saper CB, Breder CD: The neurologic basis of fever. N Engl J Med 1994;330:1880–1886.
10.
Nakajima K: Clinicopathological study of pontine hemorrhage. Stroke 1983;14:485–493.
11.
Shibata M: Hyperthermia in brain hemorrhage. Med Hypotheses 1998;50:185–190.
12.
Szczudlik A, Turaj W, Slowik A, Strojny J: Hyperthermia is not an independent predictor of greater mortality in patients with primary intracerebral hemorrhage. Med Sci Monit 2002;8:CR702–CR707.
13.
Saper CB: Brain stem modulation of sensation, movement, and consciousness; in Kandel ER, Schwartz JH, Jessell TM (eds) Principles of Neural Science, ed 4. New York, McGraw-Hill, 2000, pp 889–909.
14.
Commichau C, Scarmeas N, Mayer SA: Risk factors for fever in the neurologic intensive care unit. Neurology 2003;60:837–841.
15.
Deogaonkar A, De Georgia M, Bae C, Abou-Chebl A, Andrefsky J: Fever is associated with third ventricular shift after intracerebral hemorrhage: pathophysiologic implications. Neurol India2005;53:202–206.
16.
Przelomski MM, Roth RM, Gleckman RA, Marcus EM: Fever in the wake of a stroke. Neurology 1986;36:427–429.
17.
Boysen G, Christensen H: Stroke severity determines body temperature in acute stroke. Stroke 2001;32:413–417.
18.
Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, Sobrino T, Lizasoain I, Davalos A, Castillo J: Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J Intern Med 2006;260:343–349.
19.
Kato H, Araki T, Kogure K: Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: protective effects of MK-801 and pentobarbital. Brain Res 1990;516:175–179.
20.
Kuluz JW, Prado RJ, Dietrich WD, Schleien CL, Watson BD: The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 1993;24:2023–2029.
21.
Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422–425.
22.
Zaremba J: Hyperthermia in ischemic stroke. Med Sci Monit 2004;10:RA148–RA153.
23.
Lin SH, Chuang KL, Lin CC: Temporal patterns of body temperatures in the acute stage of stroke. Acta Neurol Taiwan 2006;15:177–183.
24.
McCarthy PW, Heusch AI: The vagaries of ear temperature assessment. J Med Eng Technol 2006;30:242–251.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.